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INTRODUCTION
Choledochal cysts, although rare in adulthood, are now cor-
rectly diagnosed more frequently due to recent improvement
in biliary imaging techniques (1). There have been numer-
ous descriptions and classifications based on the location and
anatomical structure of choledochal cyst. Among these, the
most practical classification is proposed by Alonso-Lej et al.
(2), which is modified by Todani et al. (3) in 1977. The major
point of this classification is that the gallbladder is usually
not distended and arises from a small cystic duct, usually not
at the upper end of the cyst (4). Initial reports suggested that
the following treatments provided satisfactory results: T-tube
choledochocystomy with internal or external drainage, cys-
tojejunostomy, modified cystojejunostomy with T-tube exter-
nal drainage, cyst excision and hepaticoduodenostomy, cys-
toduodenostomy, jejunal segment interposition with cysto-
duodenostomy, and jejunal segment interposition with hep-
aticojejunostomy. However, it is now recognized that these
procedures are associated with an unacceptably high rate of
late complications. Late complications of internal cyst drainage
may result in a high rate of cholangiocarcinoma arising from
the cyst (1), as well as the development of cholangitis and
biliary stone disease (1, 5-8). Surgical excision of cyst and
hepaticojejunostomy are now considered as the treatment of
choice for choledochal cysts (1, 5-8). In this paper, we describe
our experience with 72 patients with choledochal cysts.
MATERIALS AND METHODS
Seventy-two patients (59 females and 13 males) with ages
ranging from 15 to 63 (mean age=31) yr were treated for
choledochal cyst by the Department of Surgery, the second
Affiliated Hospital of Harbin Medical University, between
January 1, 1985 and December 31, 2002. The medical records
of all 72 patients were reviewed. Choledochal cysts were clas-
sified according to Alonso-Lej et al. (2) and Todani’s modified
classification system (2, 3). Follow-ups were done on all of
the patients until December 31, 2002. We analyzed the clin-
ical outcome in patients who underwent the following treat-
ments: cyst excision with hepatojejunostomy (Fig. 1), cyst
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Experience of Congenital Choledochal Cyst in Adults: Treatment, 
Surgical Procedures and Clinical Outcome in the Second Affiliated
Hospital of Harbin Medical University
This study was undertaken to analyze and evaluate the diagnosis and principal
treatment methods for congenital choledochal cyst, focusing on various surgical
procedures and clinical outcome. A comprehensive, retrospective study was con-
ducted on 72 adult patients who presented with choledochal cyst from 1985 to
2002. Surgical procedures were cyst excision with hepaticojejunostomy in 25 cases
for type I or type IV-B, extrahepatic cyst excision with hepaticojejunostomy in 8
cases for type IV-A, extrahepatic cyst excision with modified hepaticojejunostomy
in 2 cases for type IV-B, non-cyst excision with or without hepaticojejunostomy in
27 cases for types I, II, IV-A, IV-B. The early postoperative morbidity and mortality
rate were 16.1% (9/62) and 6.5% (4/62) respectively, and the complication rate
related to surgical procedure was 30.6% (19/62). The incidence of cholangiocarci-
noma with non-cyst excision or non-operated congenital choledochal cyst was
10.8% (4/37). One patient died of primary hepatocellular carcinoma after cyst exci-
sion with hepatojejunostomy. In conclusion, our results showed that complete exci-
sion of choledochal cyst for types I, II, and IV-B and complete excision of extra-
hepatic choledochal cyst from the hepatic hilum in type IV-A with hepaticojejunos-
tomy or modified hepaticojejunostomy are the treatment of choice for choledochal
cyst in adult patients.
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excision with modified hepatojejunostomy (Fig. 2), and non-
cyst excision and without hepatojejunostomy.
RESULTS
A total of 72 adult patients were identified with chole-
dochal cysts. There were 49 (68.1%) Type I or Type IV-B,
one (1.3%) Type II, 21 (29.3%) Type IV-A, and one (1.3%)
Type V choledochal cysts. Among the patients, the most
common symptom was abdominal pain, which occurred in
64 of the 72 patients (88.9%). Jaundice was present in 40
patients (55.6%), and abdominal mass was present in 21
patients (29.2%). Only eight patients (11.1%) presented
with the classic triad of abdominal pain, jaundice, and abdom-
inal mass. The biochemical measurement showed anomalies
in AST, which appeared in 22 of the 72 patients (30.6%),
ALT in 48.6%,  -GT in 31.9%, and total bilirubin in 34.7%
of all the patients. One or more of the following test proce-
dures established the diagnosis of choledochal cyst: ultra-
sonography (US) (n=49), magnetic resonance imaging (MRI)
(n=4), computed tomography (CT) (n=13) and endoscopic
retrograde cholangiopancreatography (ERCP) (n=14). The
choledochal cysts were associated with other diseases includ-
ing the pancreaticobiliary duct not filled in one case, anoma-
lous junction of the pancreatic duct and common bile duct
in one case, dilatation of pancreatic duct in one case, reten-
tion of stones in ampulla of Vater in one case, ectopic pancreas
within jejunum in one case, right hepatic duct anomaly in
one case, cyst of liver in two cases, coexistent choledocholithi-
asis in 12 cases, secondary cholestatic liver cirrhosis, which
occurred in one of the 5 cases of intrahepatic cholestasia, chole-
cystitis in 54 cases, infection of biliary tract in 29 cases and
secondary chronic pancreatitis in 5 cases. Women with chole-
dochal cyst were diagnosed during pregnancy (jaundice, abdo-
minal pain) in 3 cases (Table 1).
The definite surgical procedures were cyst excision with
hepaticojejunostomy in 25 cases for type I or type IV-B and
complete excision of extrahepatic choledochal cyst from the
hepatic hilum with hepaticojejunostomy in 8 cases for type
IV-A, extrahepatic cyst excision with modified hepaticoje-
junostomy in 2 cases for type IV-A, choledochocystomy with
internal or external drainage in 3 cases for type I or type IV-
B and 1 case in type IV-A, cyst excision and the biliary tract
reconstruction by jejunal segment interposition with hep-
aticojejunostomy (Fig. 3) in 3 cases for type I or type IV-B
and extrahepatic cyst excision and the biliary tract reconstruc-
tion by jejunal segment interposition with hepaticojejuno-
stomy in 2 cases for type IV-A, the biliary tract reconstruc-
Associated conditions No. of cases
Pancreaticobiliay duct not filled 1
Anomalous junction of the pancreatic duct and  1
common bile duct
Dilatation of pancreatic duct 1
Retention of stones in ampulla of Vater  1
Ectopic pancreas within jejunum  1
Right hepatic duct anomaly  1
Cyst of liver  2
Coexistent choledocholithiasis 12




Infection of biliary tract  29
Secondary chronic pancreatitis  5
Diagnosed during pregnancy (jaundice, abdominal pain)  3
Table 1. The associated conditions in 72 patients with chole-
dochal cyst
Fig. 1. Cyst excision with hepatojejunos-
tomy.
Fig. 2. Cyst excision with modified hepa-
tojejunostomy.
Fig. 3. Cyst excision, jejunal segment in-
terposition with hepatojejunostomy.
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tion by jejunal segment interposition with cystoduodenos-
tomy in 2 cases for type I or type IV-B, cystoduodenostomy
in 2 cases for type I or type IV-B and 1 case in type IV-A,
cyst excision and hepaticoduodenostomy in 2 cases for type
I or type IV-B and 1 case for type II, cystojejunostomy in 4
cases for type I or type IV-B and 5 cases in type IV-A, modi-
fied cystojejunostomy with T-tube external drainage for 1 case
in type IV-A (Table 2). 27 out of 62 with received operation
cases were performed non-cyst excision with or without hep-
aticojejunostomy in type I, II, IV-A, IV-B. Because of chole-
dochal cyst adhered with surrounding tissue extensively, we
can not dissect choledochal cyst from the round ligament in
27 cases. Ten out of the 72 patients did not receive operation. 
The early postoperative morbidity and mortality rates were
16.1% (9/62) and 6.5% (4/62) respectively. The complica-
tion rate related to the surgical procedure was 30.6% (19/62).
The incidence of carcinoma was 6.9% (5/72), while the inci-
dence of cholangiocarcinoma with non-cyst excision or non-
operated congenital choledochal cyst was 10.8% (4/37). Early
postoperative complications included wound infection, sep-
tic shock after cystojejunostomy in one case, acute septic peri-
tonitis after cyst excision with hepatojejunostomy in one case,
abdominal pain, pancreatic ductal dilatation with retrograde
cholangitis after cyst excision with hepatojejunostomy in one
case, which was resolved after a few days with conservative
antibiotics treatment. 
Two cases required reoperative revision in the early post-
operative period due to anastomotic leakage after cyst exci-
sion with Roux-en-Y hepaticojejunostomy. Unfortunately,
one patient died of brain infection within one week and the
other suffered from anastomotic leakage and intra-abdomi-
nal hematoma formation after cystoduodenostomy and even-
tually died of multiorgan failure within one week. During
the immediate postoperative period, one patient with fistu-
la formation after cystoduodenostomy died of hepatic failure
within 72 hr. In two cases, a 44 yr old male patient and a 37
Type Surgical procedures No. of 
cases
I or IV-B Cyst excision with hepaticojejunostomy  25
Cyst excision, and jejunal segment interposition  3
with hepaticojejunostomy 
Jejunal segment interposition with  2
cystoduodenostomy 
Cystoduodenostomy 2
Cyst excision and hepaticoduodenostomy 2
Cystojejunostomy 4
Choledochocystomy with internal or external drainage  3
IV-A Extrahepatic cyst excision with hepaticojejunostomy  8
Extrahepatic cyst excision with modified  2
hepaticojejunostomy 
Choledochocystostomy with internal or external  1
drainage




Modified cystojejunostomy with T-tube external  1
drainage 
II Cyst excision and hepaticoduodenostomy 1
Table 2. The surgical procedures according to the choledochal
cyst type in 62 out of 72 patients





1 56 I or IV-B F Cyst excision, hepatojejunostomy Acute septic peritonitis Non-operation Survived (12 yr) 
2 36 I or IV-B F Cyst excision, hepatojejunostomy Leakage of anastomosis Non-operation Survived (5 yr)
3 18 IV-A F Cyst excision, hepatojejunostomy Primary hepatocellular carcinoma Exploratory operation Died (10 yr)
4 37 I or IV-B F Cyst excision, hepatojejunostomy Cholangiocarcinoma Died (6 month)
5 44 I or IV-B M Cyst excision, hepatojejunostomy Cholangiocarcinoma Died (6 month)
6 34 I or IV-B F Cyst excision, hepatojejunostomy Brain infection Exploratory operation Died (1 week)
7 32 I or IV-B F Cyst excision, hepatojejunostomy Retrograde cholangitis Non-operation Survived (5 yr)
8 26 I or IV-B F Cyst excision, hepatojejunostomy Retrograde cholangitis Exploratory biopsy Died (10 yr)
Cholangioadenocarcinoma
9 29 IV-A F Choledochocystomy with  Retention of stones Extrahepatic cyst excision,  Survived (2 yr)
external drainage in ampulla of Vater hepatojejunostomy
10 20 I or IV-B F Cyst excision, jejunal segment Anastomosis stricture Modified hepatojejunostomy Survived (14 yr)
interposition with hepatojejunostomy
11 20 I or IV-B F Cystoduodenostomy Intra-abdominal hematoma  Died (1 week)
multiorgan failure
12 33 IV-A F Cystoduodenostomy Fistula Died (3 hr)
13 17 IV-A F Cystoduodenostomy Retrograde cholangitis Cyst excision, hepatojejunostomy Survived (14 yr)
14 25 I or IV-B F Cystoduodenostomy Retrograde cholangitis Cyst excision, hepatojejunostomy Survived (9 yr)
15 32 I or IV-B F Cystojejunostomy Cyst sclerosing cholangitis Cyst excision, hepatojejunostomy Survived (9 yr)
16 27 IV-A F Cystojejunostomy Septic shock Died (25 days)
17 28 IV-A F Cystojejunostomy Cholangiocarcinoma Cyst excision, hepatojejunostomy Died (12 yr)
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yr old female, both with type I or type IV-B, were admitted
to the hospital with (postoperative) diagnosis of well-differ-
entiated cholangiocarcinoma. Within sixth month following
cyst excision with hepaticojejunostomy, both patients died.
For one pregnant 27 yr old (type IV-A), a Roux-en-Y cysto-
jejunostomy with T-tube external drainage was performed.
However, primigravida presented at 20 weeks’ gestation, and
the patient died of septic shock and multiorgan failure on
postoperative day 25. 
The long-term complications: Of the 6 patients who were
re-hospitalized, two patients developed retrograde cholangitis
after cystoduodenostomy with internal drainage. These pati-
ents were treated cyst excision with hepatojejunostomy. Sec-
ond patient suffered from recurrent retrograde cholangitis
and subsequently developed secondary sclerosing cholangitis
10 yr after cystojejunostomy; this was resolved by cyst exci-
sion with hepatojejunostomy. One patient presented with pro-
gressive obstructive jaundice, bile duct stones, and strictures
after T-tube choledochocystostomy with external drainage
but was cured by cyst excision and hepatojejunostomy. One
case presented with anastomotic stricture after jejunal seg-
ment interposition with cystoduodenostomy and successfully
treated by cyst excision and modified hepatojejunostomy.
Another patient presented with postoperative abdominal pain
as well as retrograde cholangitis 5 yr after cystojejunostomy,
which was treated with cyst excision with hepatojejunosto-
my. One 25 yr old female patient with type IV originally
received cyst excision with hepaticojejunostomy, but devel-
oped primary hepatocellular carcinoma and died eight years
after the original procedure. A 26 yr old multiparous woman
presented at 28 weeks’ gestation with choledochal cyst with
a type I or type IV-B. This patient received Roux-en-Y cys-
tojejunostomy after a vertex delivery by induced labor at 28
weeks’ gestation. She developed intermittent retrograde cho-
langitis within 10 yr, and ultimately died of well-differenti-
ated congenital cholangioadenocarcinoma within 1 month
after re-operation with exploratory biopsy at the age of 36 yr.
One patient received cystojejunostomy for type IV-A with
development of cholangiocarcinoma in 12 yr after operation.
She received cyst excision with Rox-en-Y hepaticojejuno-
stomy, but died after one year at age 60 yr. Finally, one patient
with type IV-A died of carbon monoxide toxicosis within
six years following cystojejunostomy. Out of 72 patients, only
10 cases did not receive operation. Over the course of the
study, two patients with type I or type IV-B died of natural
causes (Table 3).
DISCUSSION 
Long after the first pathological description of a choledochal
cyst by Vatero in 1723, and the first clinical report by Dou-
glas in 1852, the aetiology of this anomaly remains contro-
versial (9). It is unclear whether the choledochal cyst is con-
genital or acquired. Two main theories emerged. In 1936,
Yotsuyanagi (9) suggested that choledochal cysts arise from
inequality in the vacuolization of the biliary tract in early
embryonic life. The common channel theory proposed by
Babbitt (9) in 1969 is presently the most widely accepted
idea. This theory is based on an anomaly of the pancreatico-
biliary junction and the formation of an abnormally long
common channel (greater than 15 mm) outside the control
of the sphincters of Boyden. Thus configuration permits pan-
creatic enzymes to reflux into the common bile duct. The pan-
creatic enzymes then lead to constant inflammation, epithelial
denudation, thinning of the bile duct wall and distal obstruc-
tion, and eventually leading to cyst formation. Although the
incidence of choledochal cysts was reported to be low (from
1 in 13,000 to 1 in 2 million patients) (1, 9), they are now
diagnosed more frequently with the use of improved diag-
nostic techniques such as US, CT, and direct cholangiogra-
phy (PTC and ERCP). 
It is necessary to classify the type of cyst and to recognize
the presence of an anomalous pancreaticobiliary duct junction,
visualization of both the biliary tree and pancreatic duct. For
this purpose, direct cholangiography, especially ERCP, is ben-
eficial. However, intraoperative cholangiography is not sen-
sitive enough to detect the presence of an anomalous pancre-
aticobiliary duct junction. Radiographic visualization of both
the biliary tree and pancreatic duct prior to surgery is helpful
for the surgical manipulation and complete excision of the
cyst (1, 10, 11). In our review, a common channel could not
be identified. Out of 14 cases, ERCP was only shown the pan-
creaticobiliary duct not filled, an anomalous junction of the
pancreatic duct and common bile duct, dilatation of pancre-
atic duct and retention of stones in the ampulla of Vater (Table
1). Therefore, no conclusion can be justified concerning the
presence or absence of a common channel in our experience.
Other pathologic features of choledochal cysts include acute
and chronic mucosal inflammation, mucosal dysplasia, and
a relative absence of smooth or elastic fibers. A true mucosal
lining may be hard to find. However, it is where present cuboi-
dal or columnar and frequently ulcerated. The cyst wall varies
from 1 to 10 mm in thickness. Mucus-producing glands are
rarely seen. There is usually a large amount of fibrosis, some
of which may be involved in luminal stenoses. The bile is
often very thick and often less pigmented than normal. Bil-
iary calculi are uncommon. Pathologic complications include
biliary obstruction, cholangitis, hepatic abscess, rupture, or
development of cancer. Cholelithiasis is unusual with chole-
dochal cysts (4). However, in our study we observed very dif-
ferent preoperative pathologic complications, as listed in Table
1. In our experience, the combination of thorough history
takings along with understanding of mechanism of manifes-
tation and pathology of disease, it is possible to correctly diag-
nose and treat congenital choladochal cyst in adults. 
Early reports suggested that internal or external drainage
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tube choledochocystomy was a satisfactory method of treat-
ment; however, with longer follow-up period, it has become
clear that complications such as suppurative cholangitis, lithi-
asis, pancreatitis, secondary biliary cirrhosis, portal hyperten-
sion, and intrahepatic abscess may manifest in up to 40 per-
cent of cases (9). That compares favorably with our results.
In our review, two cases were resolved by cyst excision with
hepatojejunostomy after T-tube choledochocystomy. One
case appeared with progressive obstructive jaundice, bile duct
stones, and strictures after T-tube choledochocystomy with
external drainage, and then re-treated by cyst excision with
hepatojejunostomy. The other case presented with anastomo-
sis stricture after jejunal segment interposition with cysto-
duodenostomy; this patient was successfully treated by cyst
excision and modified hepatojejunostomy. 
The increased risk of bile duct carcinoma in choledochal
cysts is well characterized (9). The reported incidence of bil-
iary tract carcinoma in choledochal cysts varies from 2.5% to
17.5%, which is significantly higher than that found in the
general population, which ranges from 0.01% to 0.05% (9).
The incidence of cancer in those who have undergone enteric
drainage without cyst excision is much higher than that of
carcinoma of the bile ducts in the general population. Five
patients in our study ultimately developed malignant tumors.
One 44 yr old male and one 37 yr old female with Type I or
Type IV-B carried postoperative diagnosis of a well-differen-
tiated cholangiocarcinoma. These patients were admitted to
the hospital but died within sixth months after cyst excision
with hepaticojejunostomy. In these two cases, the problem
might have been treated or avoided entirely through early
diagnosis and early cyst excision (9). The age-related incidence
of cyst-associated cancer has been shown to increase from
0.7% in the first decade of life to 14.3% after age 20. This
means the favorable outcome in congenital choledochal cyst
patients may be due to earlier detection and treatment (9),
which may be the most important issue in the successful treat-
ment of congenital choladochal cyst. 
Some authors have reported that cyst excision does not com-
pletely eliminate the risk of intrahepatic cholangiocarcinoma
after the excision of a type I cyst (9, 12-18). In our experi-
ence, one 25 yr old female patient with type IV-A received
cyst excision with hepaticojejunostomy but developed pri-
mary hepatocellular carcinoma within 8 yr of postoperation
and died. However, there is insufficient evidence in this one
case to suggest whether congenital choledochal cyst was a
direct causative factor. One gestation women with type-A
after cystojejunostomy showed repetitive intermittent retro-
grade cholangitis over a 10 yr period, then developed well-
differentiated cholangioadenocarcinoma and died at the age
36 yr. One patient with type IV-A received cystojejunosto-
my developed cholangiocarcinoma in within 12 yr postoper-
ation then received extrahepatic cyst excision from the hepatic
hilum with Roux-en-Y hepaticojejunostomy. He died after
a year at age 60 yr. Our results indicated that cysts excision
significantly decreased the incidence of bile duct carcinoma.
We thus recommend re-operation in non-cyst excision cases.
Kasai et al. (9) were the first to report the increased inci-
dence of carcinoma arising in choledochal cysts and to advo-
cate primary cyst excision. Moreover, the advances in diag-
nostic and therapeutic procedures and increased operative
experience have lowered the mortality rate to 0-7% (9). Roux-
en-Y choledochojejunostomy has replaced choledochoduo-
denostomy as the preferred operative procedure due to the
high morbidity rate from cholangitis and the frequent need
for re-operation (9). In our review, we also noted the same
complications; the patients received cyst excision with hep-
atojejunostomy.
Excision of type I, II and IV choledochal cysts is now a
widely accepted procedure because of the lowered incidence
of postoperative complications. In contrast to cyst enteros-
tomy, cyst excision with hepaticojejunostomy has demon-
strated satisfactory results (Table 3). In type I cysts, total cyst
excision showed ideal long-term follow-up results except for
one patient who developed hepatolithiasis secondary to steno-
sis of the hepaticojejunostomy. All other patients had an une-
ventful postoperative course. Although the occurrence of intra-
hepatic cholangiocarcinoma after the excision of a type I cyst
has been reported (12, 13), cyst excision remains the primary
treatment of choice for type I cyst. Type III cyst requires ade-
quate drinage and generally can be managed by endoscopic
sphincterotomy. If this procedure cannot be undertaken, oper-
ative sphincteroplasty with transduodenal cyst excision may
be attempted (1). Sphincteroplasty done either endoscopically or
surgically are a satisfactory method according to Venu et al.
(14). 
Treatment for type IV cyst is still controversial. Either exci-
sion of the extrahepatic cyst alone (1) or total cyst excision
including hepatectomy (15) has been recommended. We
have performed excision of the cyst with hepatojejunostomy
in 23 cases for type I or IV-B and excision of the extrahepat-
ic cyst with hepatojejunostomy in 8 cases for type IV-A, extra-
hepatic cyst excision and modified hepatojejunostomy in 2
cases in type IV-A (Table 2, 3). Although we did not perform
hepatectomy in type IV-A cases for complete excision of intra-
hepatic cyst, the intrahepatic cyst did not developed to cholan-
giocarcinoma in our review, only two cases due to leakage of
anastomosis after cyst excision with Roux-en-Y hepaticoje-
junostomy were performed reoperation in the early postop-
erative days. And among one case, the patient died from brain
infection within one week. Other three cases died of non-cyst
excision with hepatojejunostomy or non-cyst excision with
modified hepatojejunostomy.  
In our experience, the early postoperative morbidity and
mortality rate were 16.1% (9/62), and 6.5% (4/62). The inci-
dence of carcinoma was 6.9% (5/72), but the incidence of
biliary tract carcinoma with non-cyst excision or non-oper-
ated congenital choladochal cyst was 10.8% (4/37). It has
carried considerable number of complications as well as inci-Experience of Congenital Choledochal Cyst in Adults 847
dence of biliary tract carcinoma. However, in our experience,
we noted that the incidence of complications and incidence
of biliary tract carcinoma appeared higher in non-cyst exci-
sion with or non-hepatojejunostomy than in cyst excision
with hepatojejunostomy or cyst excision with modified hepa-
tojejunostomy.
Complete excision of the extrahepatic bile duct from the
hepatic hilum to the pancreaticobiliary duct junction is the
treatment choice for type IV cysts and I (16-19). However,
it should be mentioned that since complete excision seems
to be difficult in some cases, pancreaticoduodenectomy or
hepatic resection should also be considered. In such cases, the
distal choledochus is resected just above the pancreaticobil-
iary duct junction with the aid of preoperative ERCP and
intraoperative US to avoid injury to the pancreatic duct. In
the hepatic hilum, the hepatic duct must be resected at the
hilum, and hepaticojejunostomy with a wide opening by plas-
tic of both the hepatic ducts is necessary.
In conclusion, the surgical strategy should be selected based
on the type of cyst. We recommend that 1) complete exci-
sion of choledochal cyst for types I, II, IV-B and 2) complete
excision of extrahepatic choledochal cysts from the hepatic
hilum in type IV-A with hepaticojejunostomy or modified
hepaticojejunostomy.
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